Tag: Alzheimer’s

Meet the Lab! CCANDL Lab Director and Staff

Meet the leadership and staff behind everything we do at CCANDL:

24th Annual Update in Alzheimer’s Disease and Related Dementias Conference

This past week, our wonderful PhD Student, Phoebe, tabled at the 24th Annual Update in Alzheimer’s Disease and Related Dementias conference! This conference shares new updates on research and informs others about the practices used in memory and dementia care. There are many other opportunities that the Alzheimer’s Association has to offer, so if you …

CCANDL at AAIC 2026: Presentation Schedule and Highlights

We are thrilled to share that the CCANDL will be well-represented at the upcoming Alzheimer’s Association International Conference (AAIC26) in London, UK! Our team members, students, and collaborators will be presenting cutting-edge research covering digital speech biomarkers, subjective cognitive decline, neuroimaging, and the intersection of hearing health and cognition. If you are attending the conference …

New Publication: Proper Name Recall Improved the Ability of a Cognitive Assessment to Detect Changes Associated with Plasma p-tau217, a key Alzheimer’s disease biomarker

📣 New publication alert! Congratulations to CCANDL’s Deling He on her recent publication! This study found that incorporating proper name recall into a commonly used cognitive assessment enhanced its sensitivity to plasma p-tau217, a key biomarker for Alzheimer’s disease. Congratulations Deling!

Dr. Chin’s New Book “When Memory Fades”

We are so lucky to collaborate with such an incredible clinician and researcher. If you have the chance, check out Dr. Chin’s new book!

New Publication from CCANDL’s Biostatistician: Kristin Basche

Congratulations to CCANDL’s biostatistician Kristin Basche and collaborators on their recent publication examining proper name recall and pTau217 as potential markers of early cognitive decline in Alzheimer's disease research. This work highlights how subtle changes in memory can help identify cognitive decline earlier in at-risk adults.